Regen (@checkregen) header
Regen (@checkregen) profile picture

The #1 personalized Peptide/GLP care app.

Try Now →
Joined April 2025
REGEN product update is live we are building the most transparent peptide health startup out there. here is what we changed: + Easier Add Peptide Flow that can smart map & dosing history for any compound + Peptide Vendor Research/Breakdown Tab + Updated Community Reports on all compounds + Compound Update (44 → 67) + Complete Rewrite of Peptide Library (highest quality facts, studies, sources etc.) + Added a Peptide Encyclopedia on the Web (regenhealth[.]app) + Smoother App Perfomance + Improved Design and UX go update your apps and check us out on the web!
1
1
11
3,924
🚨BREAKING: A coroner ruled actor Richard Norton's death was triggered by a CJC-1295/Ipamorelin injection. He was taking more than his prescribed dose, and it caused a fatal allergic reaction. The coroner wants these peptides banned outside clinical trials.
1
25
CJC-1295 and Ipamorelin can cause severe allergic reactions, and the dose matters. Regen shows the research, the risks and the dose for every peptide you take. Check your peptides: regenhealth.app
6
Andrew Huberman says gray market peptides sold as 99% pure can still hurt you: – The other 1% can carry LPS, a highly inflammatory contaminant – One dose may be fine. Repeated doses are the worry
1
1
51
Peptides your body already makes: Insulin: blood sugar Oxytocin: bonding GLP-1: fullness Ghrelin: hunger Glutathione: antioxidant Which one surprised you?
1
1
24
Why is IGF-1 LR3 rated F on Regen when lifters swear by it? - It has no clinical trials for muscle growth - Its grade rests on 1 cited study through 2004 - It can sharply drop your blood sugar - It's growth-promoting, so cancer risk is a real concern
1
53
Ipamorelin vs GHRP-6 - Ipamorelin is C-tier on Regen. GHRP-6 is D-tier - Both make your pituitary release growth hormone - GHRP-6 brings strong hunger. Ipamorelin barely touches appetite - Ipamorelin was the first selective GH secretagogue
1
37
Fewer people with diabetes and kidney disease had serious side effects on semaglutide than placebo: 45.1% vs 50.4%. Even with the weakest kidneys, it was 56.4% vs 60.4%. That's from 3,533 people in the FLOW trial.
1
59
🚨BREAKING: FDA & HHS say it won't go after licensed pharmacies compounding 6 peptides, including BPC-157 and TB-500, with a prescription.
3
2
1
37
1,813